From Casetext: Smarter Legal Research

In re Lorazepam Clorazepate Antitrust Litigation

United States District Court, D. Columbia
Aug 20, 2002
MDL. 1290 (TFH/JMF), Misc. No. 99ms276, 02-CV-4598 (S.D.N.Y.) (D.D.C. Aug. 20, 2002)
Download
PDF
Check
Treatment

Opinion

MDL. 1290 (TFH/JMF), Misc. No. 99ms276, 02-CV-4598 (S.D.N.Y.)

August 20, 2002

ORDER

THOMAS F. HOGAN, United States District Court

UPON CONSIDERATION of Defendant Milan Puskar's Unopposed Motion to Continue Status Conference and there being no opposition thereto, it is this 20th day of August, 2002,

ORDERED, that the September 12, 2002 status conference is continued to September 19, 2002. @ 2:00 p.m.

Summaries of

In re Lorazepam Clorazepate Antitrust Litigation

United States District Court, D. Columbia
Aug 20, 2002
MDL. 1290 (TFH/JMF), Misc. No. 99ms276, 02-CV-4598 (S.D.N.Y.) (D.D.C. Aug. 20, 2002)
Case details for

In re Lorazepam Clorazepate Antitrust Litigation

Case Details

Full title:IN RE LORAZEPAM CLORAZEPATE ANTITRUST LITIGATION. This document relates…

Court:United States District Court, D. Columbia

Date published: Aug 20, 2002

Citations

MDL. 1290 (TFH/JMF), Misc. No. 99ms276, 02-CV-4598 (S.D.N.Y.) (D.D.C. Aug. 20, 2002)